181 related articles for article (PubMed ID: 12645018)
1. Novel carboranyl C-glycosides for the treatment of cancer by boron neutron capture therapy.
Tietze LF; Griesbach U; Schuberth I; Bothe U; Marra A; Dondoni A
Chemistry; 2003 Mar; 9(6):1296-302. PubMed ID: 12645018
[TBL] [Abstract][Full Text] [Related]
2. Preparation of a new carboranyl lactoside for the treatment of cancer by boron neutron capture therapy: synthesis and toxicity of fluoro carboranyl glycosides for in vivo 19F-NMR spectroscopy.
Tietze LF; Bothe U; Schuberth I
Chemistry; 2000 Mar; 6(5):836-42. PubMed ID: 10826605
[TBL] [Abstract][Full Text] [Related]
3. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
Genady AR
Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378
[TBL] [Abstract][Full Text] [Related]
4. Carboranyl bisglycosides for the treatment of cancer by boron neutron capture therapy.
Tietze LF; Bothe U; Griesbach U; Nakaichi M; Hasegawa T; Nakamura H; Yamamoto Y
Chembiochem; 2001 May; 2(5):326-34. PubMed ID: 11828461
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new boron-rich building blocks for boron neutron capture therapy or energy-filtering transmission electron microscopy.
Raddatz S; Marcello M; Kliem HC; Tröster H; Trendelenburg MF; Oeser T; Granzow C; Wiessler M
Chembiochem; 2004 Apr; 5(4):474-82. PubMed ID: 15185371
[TBL] [Abstract][Full Text] [Related]
6. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of functionalized carboranes as potential anticancer and BNCT agents.
Reddy VJ; Roforth MM; Tan C; Reddy MV
Inorg Chem; 2007 Jan; 46(2):381-3. PubMed ID: 17279815
[TBL] [Abstract][Full Text] [Related]
8. Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT).
Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA
Crit Rev Oncol Hematol; 2008 Oct; 68(1):66-90. PubMed ID: 18439836
[TBL] [Abstract][Full Text] [Related]
9. Ortho-carboranyl glycosides for the treatment of cancer by boron neutron capture therapy.
Tietze LF; Bothe U; Griesbach U; Nakaichi M; Hasegawa T; Nakamura H; Yamamoto Y
Bioorg Med Chem; 2001 Jul; 9(7):1747-52. PubMed ID: 11425576
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine.
Cai J; Hosmane NS; Takagaki M; Zhu Y
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066470
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of new shikonin glycosides.
Su Y; Xie J; Wang Y; Hu X; Lin X
Eur J Med Chem; 2010 Jul; 45(7):2713-8. PubMed ID: 20403646
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of indirubin-N'-glycosides and their anti-proliferative activity against human cancer cell lines.
Libnow S; Methling K; Hein M; Michalik D; Harms M; Wende K; Flemming A; Köckerling M; Reinke H; Bednarski PJ; Lalk M; Langer P
Bioorg Med Chem; 2008 May; 16(10):5570-83. PubMed ID: 18434163
[TBL] [Abstract][Full Text] [Related]
13. Efficient synthesis of alpha- and beta-chacotriosyl glycosides using appropriate donors, and their cytotoxic activity.
Miyashita H; Kai Y; Nohara T; Ikeda T
Carbohydr Res; 2008 Jun; 343(8):1309-15. PubMed ID: 18440498
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of furanosyl alpha-C-glycosides derived from 4-chloro-4-deoxy-alpha-D-galactose and their cytotoxic activities.
Yan L; Dai GF; Yang JL; Liu FW; Liu HM
Bioorg Med Chem Lett; 2007 Jun; 17(12):3454-7. PubMed ID: 17462891
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of carboranes containing an azulene framework and in vitro evaluation as boron carriers.
Nakamura H; Sekido M; Yamamoto Y
J Med Chem; 1997 Aug; 40(18):2825-30. PubMed ID: 9288164
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy.
Tietze LF; von Hof JM; Krewer B; Müller M; Major F; Schuster HJ; Schuberth I; Alves F
ChemMedChem; 2008 Dec; 3(12):1946-55. PubMed ID: 19021160
[TBL] [Abstract][Full Text] [Related]
18. Hydrophilically enhanced 3-carboranyl thymidine analogues (3CTAs) for boron neutron capture therapy (BNCT) of cancer.
Narayanasamy S; Thirumamagal BT; Johnsamuel J; Byun Y; Al-Madhoun AS; Usova E; Cosquer GY; Yan J; Bandyopadhyaya AK; Tiwari R; Eriksson S; Tjarks W
Bioorg Med Chem; 2006 Oct; 14(20):6886-99. PubMed ID: 16831554
[TBL] [Abstract][Full Text] [Related]
19. New oxypregnane glycosides from appetite suppressant herbal supplement Hoodia gordonii.
Pawar RS; Shukla YJ; Khan SI; Avula B; Khan IA
Steroids; 2007 Jun; 72(6-7):524-34. PubMed ID: 17467018
[TBL] [Abstract][Full Text] [Related]
20. Carboranyl thymidine analogues for neutron capture therapy.
Tjarks W; Tiwari R; Byun Y; Narayanasamy S; Barth RF
Chem Commun (Camb); 2007 Dec; (47):4978-91. PubMed ID: 18049729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
